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Assessment of acid–base disorders
To the Editor: Adrogue´ et al.1 give an overview of the three
distinct approaches that are currently used in assessing
acid–base disorders. In contrast to their assumption that the
chloride level is normal in high anion gap acidosis (Table 2),
there is often a low plasma chloride level because the plasma
chloride decreases relative to sodium in these cases.2 They
also assume that there is no signiﬁcant effect of the plasma
albumin on acid–base status in the physiological approach.
This is not the case, as we have to adjust the anion gap for the
plasma albumin.1 Indeed, after this adjustment there is no
effect of albumin on the metabolic acid–base component. In
the clinical case example 2, the authors give the impression
that the physiological approach acknowledges a metabolic
alkalosis and the physicochemical approach only diagnoses a
hypoalbuminemic alkalosis. This is probably not true. A
decrease in plasma albumin level by 1 g/dl usually results in
an increase in bicarbonate level by 2.8mmol/l.3 Accordingly,
with a serum albumin level of 1.5mmol/l, the expected serum
bicarbonate level in this case will be 24þ 3 2.8
(8.4)¼ 32.4mmol/l. The patient’s serum bicarbonate is higher
(35mmol/l), probably because of an additional metabolic
alkalosis caused by the low potassium level of 3.2mmol/l. In
this context, the two approaches are therefore less different
than the authors suggest. The fact that the secondary DPaCO2
is not deﬁned in metabolic acidosis and alkalosis according to
the physicochemical approach1 is probably the most im-
portant limitation of this method, as additional respiratory
disturbances may be missed.
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The Authors Reply: We respectfully disagree with the
comments made by Dr Berend.1 The study he quoted to
counter our ‘assumption that the chloride level is normal in
high anion gap acidosis’ failed to detect absolute hypochlor-
emia in patients with this condition.2 Thus, normochloremic
acidosis is an appropriate and standard term for high anion
gap acidosis. This term allows differentiation of high anion
gap acidosis from the normal anion gap acidosis that features
hyperchloremia.
The need to adjust the plasma anion gap for the anionic
charge of plasma albumin, a simple computation performed
routinely by clinicians, is unrelated to the proposed effect of
albumin itself on acid–base status. As stated in our paper,3
there is no evidence that the body, and in particular, the liver,
regulates albumin to maintain acid–base balance. A role of
albumin itself in the regulation of acid–base status is accepted
by neither the physiological nor the base-excess approach.
Dr Berend claims that our assessment of example 2 is pro-
bably incorrect because we did not consider that a decrease in
plasma albumin by 1 g/dl results in an increase in bicarbonate
by 2.8mmol/l. As this claim is based on a simple associative
relationship,4 it provides no support for a cause-and-effect
relationship of albumin to plasma bicarbonate.
Finally, the lack of deﬁnition of the secondary ventilatory
response to metabolic acid–base disorders is indeed one of the
limitations of the physicochemical approach, but certainly not
its most serious drawback, as Dr Berend asserts.
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